International Conference on Immunoengineering and Vaccine Design Technologies
ICIIVDT
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest advancements in immunoengineering, emphasizing novel approaches to manipulate the immune system for therapeutic purposes. Researchers are encouraged to present their findings on engineered immune cells and biomaterials that enhance immune responses.
SDG 3
SDG 4
This session will explore cutting-edge technologies in vaccine design, including mRNA platforms, viral vectors, and nanoparticle-based delivery systems. Contributions that highlight the integration of computational modeling in vaccine development are particularly welcome.
SDG 3
SDG 9
This track aims to discuss computational and mathematical models that simulate immune system dynamics and responses. Presentations should focus on the implications of these models for predicting outcomes in immunotherapy and vaccine efficacy.
SDG 3
SDG 9
This session will highlight the role of biomedical engineering in the design and production of vaccines. Topics may include bioprocess engineering, formulation strategies, and quality control measures that enhance vaccine safety and effectiveness.
SDG 3
SDG 9
This track will delve into the use of synthetic biology techniques to engineer immune cells and create novel immunotherapeutics. Researchers are invited to share their insights on gene editing, synthetic circuits, and their applications in combating diseases.
SDG 3
SDG 9
This session will focus on methodologies for optimizing drug development processes, particularly in the context of immunotherapeutics. Contributions that address system biology approaches and high-throughput screening techniques are encouraged.
SDG 3
SDG 9
This track will explore the application of bioinformatics tools and techniques in the field of immunoengineering. Presentations should focus on data analysis, predictive modeling, and the integration of omics data to enhance vaccine design.
SDG 3
SDG 9
This session will cover the latest breakthroughs in immunotherapy, including checkpoint inhibitors, CAR-T cell therapy, and personalized medicine approaches. Researchers are invited to discuss clinical outcomes and novel strategies to enhance therapeutic efficacy.
SDG 3
SDG 9
This track will examine innovative solutions in healthcare driven by immunoengineering principles. Topics may include the development of point-of-care diagnostics, vaccine delivery systems, and strategies to improve patient outcomes.
SDG 3
SDG 9
This session will focus on the engineering of effective vaccine delivery systems, including microneedles, liposomes, and other novel carriers. Researchers are encouraged to present their work on enhancing bioavailability and immune response through innovative delivery methods.
SDG 3
SDG 9
This track will explore the intersection of computational biology and life sciences, particularly in the context of immunology and vaccine design. Presentations should highlight the use of algorithms, simulations, and data analytics to advance our understanding of immune responses.
SDG 3
SDG 9